Post-approval studies (Phase 4)Study completedNCT03293030
What this trial is testing
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more
University of California, San Francisco 17